Effect of Renexin tablet in patients with recurrent vestibulopathy
Not Applicable
Recruiting
- Conditions
- Diseases of the ear and mastoid process
- Registration Number
- KCT0000987
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Adults who complain repetitive vertigo and are diagnosed as recurrent vestibulopahty with VAS scrore between 4 and 8
Exclusion Criteria
- patients with diagnosis of central type vertigo confirmed by MRI
- patients who recently diagnosed for peripheral vestibular disorders such as benign paroxysmal vertigo, Meniere's disease, migraine induced vertigo
- patients with bilateral vestibular function loss
- patients with acute vestibular neuritis occured within last 6 months
- patients with chronic liver disease, anemia
- pregnant or breast-feeding females
- patients with medication such as phenobarbital, phenytoin, carbamazepin, or ripampicin
- patients with medication of cilostazol or Ginko biloba at present
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method dizziness handicap inventory;visual analogue scale;SF-36
- Secondary Outcome Measures
Name Time Method safety of medication